Open Outbreak

我应该担心野生脊髓灰质炎病毒和疫苗衍生病毒吗?

更新于 · 依据官方评估分级;此处内容不构成医疗建议。

脊髓灰质炎病毒(野生和疫苗衍生) · 关注度: 较高

如果您在受影响地区 中
WHO assessed the risk of further spread within Israel as moderate on 20 August 2025. That assessment concerns Israel’s vaccine-derived poliovirus outbreak, not the November 2026 detections in Syria. 根据 WHO
如果您在同一国家或地区的其他地方 中
WHO’s 20 August 2025 assessment put the risk of further spread within Israel at moderate because immunity gaps persisted. It is not a current assessment for all countries affected by polio. 根据 WHO
如果您即将前往那里 高
WHO’s 20 May 2025 assessment for Papua New Guinea put the risk of international spread at high. This is an outbreak-specific assessment, not a current rating for travel to Syria or Pakistan. 根据 WHO
如果您在世界其他地方 低
WHO assessed the global risk associated with Israel’s outbreak as low on 20 August 2025. That assessment does not cover all worldwide poliovirus activity in November 2026. 根据 WHO

正在发生什么

Poliovirus remains an active worldwide concern, but updates from 7–20 November 2026 mainly describe activity in Syria and Pakistan and do not establish a current global case total. WHO’s 9 November notice reported two confirmed cases and one suspected case in Deir Ezzor, Syria; these official figures come from the notice’s extracted summary because its full text was unavailable. Media reported three confirmed Syrian cases on 20 November, attributed to the health ministry but unverified, and it remains unclear whether the additional confirmation was the previously suspected case. Pakistani media, citing eradication authorities, reported nine cases for 2026 and more than 24 million children vaccinated, both unverified media-carried statements. Officials are conducting a coordinated public-health response in Syria, while Pakistan has continued a large vaccination campaign.

谁会受影响以及如何传播

脊髓灰质炎是由脊髓灰质炎病毒引起的,大多数感染不会导致明显的疾病,尽管有些会导致永久性瘫痪。它主要通过粪便中的病毒通过被污染的手、水、食物或表面传播。野生脊髓灰质炎病毒仍在少数地方循环,而疫苗衍生病毒可以在免疫水平低的地方引发疫情。接种疫苗可以预防脊髓灰质炎,但没有治愈方法。

我们关注的事项

更新

来源